Literature DB >> 20570369

CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes.

S Piccinin1, S Di Angelantonio, A Piccioni, R Volpini, G Cristalli, B B Fredholm, C Limatola, F Eusebi, D Ragozzino.   

Abstract

We characterized the role of adenosine receptor (AR) subtypes in the modulation of glutamatergic neurotransmission by the chemokine fractalkine (CX3CL1) in mouse hippocampal CA1 neurons. CX(3)CL1 causes a reversible depression of excitatory postsynaptic current (EPSC), which is abolished by the A(3)R antagonist MRS1523, but not by A(1)R (DPCPX) or A(2A)R (SCH58261) antagonists. Consistently, CX3CL1-induced EPSC depression is absent in slices from A(3)R(-/-) but not A(1)R(-/-) or A(2A)R(-/-) mice. Further, A(3)R stimulation causes similar EPSC depression. In cultured neurons, CX3CL1-induced depression of AMPA current shows A(1)R-A(3)R pharmacology. We conclude that glutamatergic depression induced by released adenosine requires the stimulation of different ARs. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570369     DOI: 10.1016/j.jneuroim.2010.05.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  19 in total

1.  When GABA Fails: Rundown on Chemokines.

Authors:  Detlev Boison
Journal:  Epilepsy Curr       Date:  2014-05       Impact factor: 7.500

Review 2.  Microglia: Dynamic Mediators of Synapse Development and Plasticity.

Authors:  Yuwen Wu; Lasse Dissing-Olesen; Brian A MacVicar; Beth Stevens
Journal:  Trends Immunol       Date:  2015-10       Impact factor: 16.687

Review 3.  A microglia-cytokine axis to modulate synaptic connectivity and function.

Authors:  Sebastian Werneburg; Philip A Feinberg; Kasey M Johnson; Dorothy P Schafer
Journal:  Curr Opin Neurobiol       Date:  2017-11-06       Impact factor: 6.627

4.  Microglial control of neuronal activity.

Authors:  Catherine Béchade; Yasmine Cantaut-Belarif; Alain Bessis
Journal:  Front Cell Neurosci       Date:  2013-03-28       Impact factor: 5.505

5.  Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity.

Authors:  Jenny Dworzak; Benoît Renvoisé; Johnny Habchi; Emma V Yates; Christophe Combadière; Tuomas P Knowles; Christopher M Dobson; Craig Blackstone; Ole Paulsen; Philip M Murphy
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

Review 6.  Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders.

Authors:  Michael J Stuart; Gaurav Singhal; Bernhard T Baune
Journal:  Front Cell Neurosci       Date:  2015-09-10       Impact factor: 5.505

7.  Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity.

Authors:  Maria Scianni; Letizia Antonilli; Giuseppina Chece; Gloria Cristalli; Maria Amalia Di Castro; Cristina Limatola; Laura Maggi
Journal:  J Neuroinflammation       Date:  2013-08-27       Impact factor: 8.322

8.  Involvement of CX3CL1/CX3CR1 signaling in spinal long term potentiation.

Authors:  Chao Bian; Zhi-Qi Zhao; Yu-Qiu Zhang; Ning Lü
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

9.  Basal adenosine modulates the functional properties of AMPA receptors in mouse hippocampal neurons through the activation of A1R A2AR and A3R.

Authors:  Silvia Di Angelantonio; Cristina Bertollini; Sonia Piccinin; Maria Rosito; Flavia Trettel; Francesca Pagani; Cristina Limatola; Davide Ragozzino
Journal:  Front Cell Neurosci       Date:  2015-10-12       Impact factor: 5.505

Review 10.  Microglia control neuronal network excitability via BDNF signalling.

Authors:  Francesco Ferrini; Yves De Koninck
Journal:  Neural Plast       Date:  2013-09-05       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.